Refractory Status Epilepticus Clinical Trial
Official title:
Application of Targeting Transcranial Direct Current Stimulation (tDCS) Stimulation in the Treatment of Refractory Status Epilepticus
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
After being informed about the study and potential risks, the recruited patients, giving written informed consent, will be determined of the eligibility for study entry. The patients who meet the eligibility requirements will be randomized in a 1:1 ratio to undergo targeting tDCS stimulation (up to 10 times) or sham stimulation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01796574 -
Ketogenic Diet for Refractory Status Epilepticus
|
N/A | |
| Withdrawn |
NCT05814523 -
To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)
|
Phase 3 | |
| Not yet recruiting |
NCT05830864 -
Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus
|
||
| Not yet recruiting |
NCT05684978 -
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
|
Phase 4 | |
| Recruiting |
NCT05851391 -
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
|
Phase 2 | |
| Recruiting |
NCT05934903 -
Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus
|
N/A | |
| Completed |
NCT04333082 -
Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction
|